CPhI Online

- Market News

Hovione Technology unveils collaboration for new asthma product in Turkey

1 Sep 2020

Ventofor Combi Fix delivered by the PowdAir Plus dry powder inhaler.

Bilim Pharmaceuticals, a Turkish company manufacturing and marketing pharmaceutical drugs, H&T Presspart, a global provider of respiratory drug-delivery devices and components to the pharmaceutical sector, and Hovione Technology, a pharmaceutical specialist in the development of innovative pulmonary device technology, have unveiled a collaboration supporting Bilim Pharmaceutical’s launch into the Turkish market of Ventofor Combi Fix, a formulation of budesonide formoterol for asthma and COPD management, delivered by the PowdAir Plus Dry Powder Inhaler (DPI).

In Turkey, there is growing patient demand for effective, readily accessible and affordable respiratory treatments.

Aiming at fulfilling these patient needs, the three companies have been collaborating in Bilim Pharmaceuticals’ development program to bring into the Turkish market Ventofor Combi Fix delivered by the PowdAir Plus DPI (dry powder inhaler), an innovative capsule DPI providing maximum simplicity, ease of use and affordability.

The PowdAir Plus DPI is exclusively manufactured and commercialized by H&T Presspart under patent license from Hovione Technology.

“We are delighted to have started an inhalation collaboration with Bilim Pharmaceuticals and that they selected our PowdAir Plus DPI to bring Ventofor Combi Fix to patients’ hands. We are also happy to continue our partnership with H&T Presspart to turn our patented inhaler technology into a commercial-ready product that is now globally available to pharmaceutical companies,” said Peter Villax, Hovione Technology’s CEO.

Read More

Related Content